Laboratory research context

TB-500 is a synthetic sequence marketed as a thymosin beta-4 fragment. Laboratory research has examined fragment-related questions involving actin dynamics, cytoskeletal organization, cell migration, inflammatory signaling, and tissue-remodeling pathways.

Pathway studied

No established receptor has been identified for the marketed fragment. Its research rationale is extrapolated from thymosin-beta-4-related actin and cytoskeletal pathways; fragment-specific pharmacology remains uncertain.

Research Use Only (RUO) Notice

This product is intended solely for laboratory research purposes by qualified researchers. It is not intended for human or veterinary use, clinical application, therapeutic use, diagnostic procedures, food use, cosmetic use, or use as a medical device.

By purchasing this product, the purchaser acknowledges that they understand the nature of the materials and agree that they will be used only in accordance with all applicable laws, regulations, and accepted laboratory practices.

Wheat State Research makes no representations regarding the suitability of this product for any use other than legitimate laboratory research. The purchaser assumes all responsibility for the safe handling, storage, and use of these materials.

Products offered by Wheat State Research have not been evaluated by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or any intended use. No claims are made regarding medical, therapeutic, diagnostic, or preventive applications.